Catalyst Biosciences, Inc. announced the appointment of Mr. Charles Democko as Senior Vice President, Regulatory Affairs. Mr. Democko brings over 20 years of regulatory affairs experience in the development of both biologics and small molecules ranging from pre-IND through commercial stage companies across several therapeutic areas. Mr. Democko will lead the regulatory efforts for the company’s rare hematologic and systemic complement-mediated disorders portfolio.